David B. Liss

511 total citations
20 papers, 305 citations indexed

About

David B. Liss is a scholar working on Public Health, Environmental and Occupational Health, Epidemiology and Anesthesiology and Pain Medicine. According to data from OpenAlex, David B. Liss has authored 20 papers receiving a total of 305 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Public Health, Environmental and Occupational Health, 7 papers in Epidemiology and 5 papers in Anesthesiology and Pain Medicine. Recurrent topics in David B. Liss's work include Opioid Use Disorder Treatment (9 papers), HIV, Drug Use, Sexual Risk (5 papers) and Forensic Toxicology and Drug Analysis (4 papers). David B. Liss is often cited by papers focused on Opioid Use Disorder Treatment (9 papers), HIV, Drug Use, Sexual Risk (5 papers) and Forensic Toxicology and Drug Analysis (4 papers). David B. Liss collaborates with scholars based in United States and Canada. David B. Liss's co-authors include Evan S. Schwarz, Michael E. Mullins, Michael J. Durkin, Laura R. Marks, Stephen Y. Liang, David K. Warren, Nathanial S Nolan, Rachel Winograd, Candice Woolfolk and Erin J. Stringfellow and has published in prestigious journals such as SHILAP Revista de lepidopterología, Annals of Internal Medicine and Clinical Infectious Diseases.

In The Last Decade

David B. Liss

20 papers receiving 304 citations

Peers

David B. Liss
Sarah Welch United States
Ryan Feldman United States
Joseph H. Donroe United States
Francis Wolf United States
Cathy Voide Switzerland
Sara E. Parli United States
S Viswanathan United States
Matthew V. Ronan United States
Mark McLean Canada
G. Michels Germany
Sarah Welch United States
David B. Liss
Citations per year, relative to David B. Liss David B. Liss (= 1×) peers Sarah Welch

Countries citing papers authored by David B. Liss

Since Specialization
Citations

This map shows the geographic impact of David B. Liss's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David B. Liss with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David B. Liss more than expected).

Fields of papers citing papers by David B. Liss

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David B. Liss. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David B. Liss. The network helps show where David B. Liss may publish in the future.

Co-authorship network of co-authors of David B. Liss

This figure shows the co-authorship network connecting the top 25 collaborators of David B. Liss. A scholar is included among the top collaborators of David B. Liss based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David B. Liss. David B. Liss is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Borgundvaag, Bjug, Fernanda Bellolio, Evan S. Schwarz, et al.. (2024). Guidelines for Reasonable and Appropriate Care in the Emergency Department (GRACE‐4): Alcohol use disorder and cannabinoid hyperemesis syndrome management in the emergency department. Academic Emergency Medicine. 31(5). 425–455. 8 indexed citations
2.
Bogdan, Ryan, David B. Liss, Emma C. Johnson, et al.. (2024). Characteristics of women concordant and discordant for urine drug screens for cannabis exposure and self-reported cannabis use during pregnancy. Neurotoxicology and Teratology. 103. 107351–107351. 2 indexed citations
3.
Farnsworth, Christopher W, et al.. (2024). Xylazine Pharmacokinetics in Patients Testing Positive for Fentanyl and Xylazine. Clinical Chemistry. 71(2). 266–273. 7 indexed citations
4.
Mueller, Kristen L., Benjamin P. Cooper, Daphne Lew, et al.. (2023). Incidence of and Factors Associated With Recurrent Firearm Injury Among Patients Presenting to St. Louis Trauma Centers, 2010 to 2019. Annals of Internal Medicine. 176(9). 1163–1171. 7 indexed citations
5.
6.
7.
Winograd, Rachel, Candice Woolfolk, Claire A. Wood, et al.. (2022). To Prescribe or Not to Prescribe?: Barriers and Motivators for Progressing Along Each Stage of the Buprenorphine Training and Prescribing Path. The Journal of Behavioral Health Services & Research. 50(2). 165–180. 12 indexed citations
8.
Stephens, Robert J., et al.. (2022). Benzonatate Overdose Presenting as Cardiac Arrest with Rapidly Narrowing QRS Interval. Journal of Medical Toxicology. 18(4). 344–349. 4 indexed citations
9.
Marks, Laura R., Hilary Reno, Stephen Y. Liang, et al.. (2021). Value of Packaged Testing for Sexually Transmitted Infections for Persons who Inject Drugs Hospitalized With Serious Injection-Related Infections. Open Forum Infectious Diseases. 8(11). ofab489–ofab489. 11 indexed citations
10.
Liss, David B. & Michael E. Mullins. (2021). Antithrombotic and Antiplatelet Drug Toxicity. Critical Care Clinics. 37(3). 591–604. 6 indexed citations
11.
Schwarz, Evan S., et al.. (2021). Methadone vs. Buprenorphine for In-Hospital Initiation: Which Is Better for Outpatient Care Retention in Patients with Opioid Use Disorder?. Journal of Medical Toxicology. 18(1). 11–18. 14 indexed citations
12.
Marks, Laura R., et al.. (2021). Care cascade for patients with opioid use disorder and serious injection related infections. SHILAP Revista de lepidopterología. 5(1). 6–10. 15 indexed citations
13.
Liss, David B., et al.. (2021). In-vitro study of lithium binding by sodium zirconium cyclosilicate (Lokelma®) or patiromer (Veltassa®). SHILAP Revista de lepidopterología. 5(1). 161–164. 1 indexed citations
14.
Marks, Laura R., Stephen Y. Liang, Evan S. Schwarz, et al.. (2020). Evaluation of Partial Oral Antibiotic Treatment for Persons Who Inject Drugs and Are Hospitalized With Invasive Infections. Clinical Infectious Diseases. 71(10). e650–e656. 47 indexed citations
15.
Marks, Laura R., David K. Warren, David B. Liss, et al.. (2019). A Comparison of Medication for Opioid Use Disorder Treatment Strategies for Persons Who Inject Drugs With Invasive Bacterial and Fungal Infections. The Journal of Infectious Diseases. 222(Supplement_5). S513–S520. 27 indexed citations
16.
Bradley, Evan S., et al.. (2019). Potential uses of naltrexone in emergency department patients with opioid use disorder. Clinical Toxicology. 57(9). 753–759. 1 indexed citations
17.
Liss, David B., Todd M. Phillips, Anthony F. Pizon, & Evan S. Schwarz. (2017). Delayed seizures in bupropion overdose with concomitant ingestion of alpha-2 agonist: a case report. 1(1). 15–17. 2 indexed citations
18.
Liss, David B., et al.. (2016). Do heroin overdose patients require observation after receiving naloxone?. Clinical Toxicology. 55(2). 81–87. 49 indexed citations
19.
20.
Liss, David B.. (2010). Hypercoagulability and Adrenal Dysfunction in Critical Care. 31(8). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sarah Welch Breakdown of academic impact, for papers by Ryan Feldman Breakdown of academic impact, for papers by Joseph H. Donroe Breakdown of academic impact, for papers by Francis Wolf Breakdown of academic impact, for papers by Cathy Voide Breakdown of academic impact, for papers by Sara E. Parli Breakdown of academic impact, for papers by S Viswanathan Breakdown of academic impact, for papers by Matthew V. Ronan Breakdown of academic impact, for papers by Mark McLean Breakdown of academic impact, for papers by G. Michels
Rankless by CCL
2026